We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+29.92%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$7.08B
AUM Growth
+$501M
(+7.6%)
Cap. Flow
-$632M
Cap. Flow
% of AUM
-8.93%
Top 10 Holdings %
Top 10 Hldgs %
18.62%
Holding
693
New
244
Increased
77
Reduced
165
Closed
197
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$109M |
| 2 |
Adobe
ADBE
|
+$89.2M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$78.8M |
| 4 |
Advantage Solutions
ADV
|
+$73.4M |
| 5 |
Joby Aviation
JOBY
|
+$54.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$91.2M |
| 2 |
Paycom
PAYC
|
+$79.5M |
| 3 |
Target
TGT
|
+$66.2M |
| 4 |
Workday
WDAY
|
+$61.2M |
| 5 |
Fortive
FTV
|
+$59.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 15.18% |
| 3 | Industrials | 12.93% |
| 4 | Financials | 11.32% |
| 5 | Consumer Discretionary | 11.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDAK
376
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $1.93M | 0.03% |
+59,841
| New | +$792K |
|
|
SCPH
377
DELISTED
scPharmaceuticals
SCPH
| $1.88M | 0.03% |
355,690
-2,845
| -0.8% | -$22.3K |
|
378
Aptevo Therapeutics
APVO
$5.01M
| – | – |
0
| – | – |
|
|
ETNB
379
DELISTED
89bio
ETNB
| $1.81M | 0.03% |
74,405
-7,971
| -10% | -$204K |
|
380
Harmony Biosciences
HRMY
$2.27B
| $1.81M | 0.03% |
+50,000
| New | +$2.02M |
|
381
Protara Therapeutics
TARA
$231M
| $1.8M | 0.03% |
74,405
-125,595
| -63% | -$2.71M |
|
382
Schrodinger
SDGR
$1.4B
| $1.78M | 0.03% |
+22,542
| New | +$1.42M |
|
383
Annexon
ANNX
$883M
| $1.75M | 0.02% |
+70,000
| New | +$1.8M |
|
384
Mirum Pharmaceuticals
MIRM
$6.02B
| $1.74M | 0.02% |
99,421
+49,443
| +99% | +$972K |
|
|
FMTX
385
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.73M | 0.02% |
+49,603
| New | +$2.16M |
|
|
RPTX
386
DELISTED
Repare Therapeutics
RPTX
| $1.73M | 0.02% |
50,330
-100,400
| -67% | -$3M |
|
387
CrowdStrike
CRWD
$229B
| $1.7M | 0.02% |
+32,000
| New | +$1.25M |
|
388
iRhythm Holdings
IRTC
$4.11B
| $1.68M | 0.02% |
+7,067
| New | +$1.61M |
|
389
Dyne Therapeutics
DYN
$4.95B
| $1.65M | 0.02% |
78,566
+49,371
| +169% | +$977K |
|
390
Telos
TLS
$302M
| $1.65M | 0.02% |
+50,000
| New | +$1.19M |
|
|
PING
391
DELISTED
Ping Identity Holding Corp.
PING
| $1.53M | 0.02% |
+53,605
| New | +$1.48M |
|
392
Boston Scientific
BSX
$73.1B
| $1.51M | 0.02% |
+42,040
| New | +$1.52M |
|
|
ABCM
393
DELISTED
Abcam PLC
ABCM
| $1.51M | 0.02% |
+70,000
| New | +$1.36M |
|
|
AUTL
394
Autolus Therapeutics
AUTL
$551M
| $1.48M | 0.02% |
165,809
-1,327
| -0.8% | -$14.1K |
|
|
HPX
395
DELISTED
HPX Corp.
HPX
| $1.46M | 0.02% |
+145,160
| New | +$1.43M |
|
396
BILL Holdings
BILL
$4.91B
| $1.45M | 0.02% |
10,637
-14,363
| -57% | -$1.69M |
|
|
MTCR
397
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $1.41M | 0.02% |
179,782
-1,438
| -0.8% | -$13.2K |
|
398
BioAtla
BCAB
$5.76M
| $1.36M | 0.02% |
+800
| New | +$1.34M |
|
|
OPTU
399
Optimum Communications Inc
OPTU
$306M
| $1.34M | 0.02% |
35,479
-963
| -3% | -$30.2K |
|
400
Taysha Gene Therapies
TSHA
$1.83B
| $1.33M | 0.02% |
50,000
-400
| -0.8% | -$8.62K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q4 2020 Portfolio in Review
As of Q4 2020, Alyeska Investment Group held 693 positions worth $7.08B, up 7.6% from $6.58B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Alyeska Investment Group withdrew a net $632M in Q4 2020, closing 197 positions and reducing 165 holdings. Its most notable exit was Analog Devices, an estimated $91.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Alyeska Investment Group opened a new position in Joby Aviation worth $56.5M.
- Alyeska Investment Group's largest Q4 2020 buy was Joby Aviation: 4,885,298 shares worth $56.5M.
- Alyeska Investment Group added most to Vertiv in Q4 2020, an estimated $109M increase.
- Alyeska Investment Group's biggest Q4 2020 reduction was Paycom, cutting an estimated $79.5M.
- Alyeska Investment Group fully exited Analog Devices in Q4 2020, selling an estimated $91.2M.
- Alyeska Investment Group's ten largest holdings make up 19% of its $7.08B portfolio in Q4 2020.
- Alyeska Investment Group opened 244 new positions and closed 197 in Q4 2020.
- Alyeska Investment Group's portfolio value rose 7.6% quarter-over-quarter to $7.08B.
Based on Alyeska Investment Group's 13F filing for Q4 2020, filed 16 Feb 2021.